| First Author | Moon JB | Year | 2012 |
| Journal | J Immunol | Volume | 188 |
| Issue | 1 | Pages | 163-9 |
| PubMed ID | 22131333 | Mgi Jnum | J:180812 |
| Mgi Id | MGI:5307937 | Doi | 10.4049/jimmunol.1101254 |
| Citation | Moon JB, et al. (2012) Akt induces osteoclast differentiation through regulating the GSK3beta/NFATc1 signaling cascade. J Immunol 188(1):163-9 |
| abstractText | SHIP is an SH2-containing inositol-5-phosphatase expressed in hematopoietic cells. It hydrolyzes the PI3K product PI(3,4,5)P(3) and blunts the PI3K-initiated signaling pathway. Although the PI3K/Akt pathway has been shown to be important for osteoclastogenesis, the molecular events involved in osteoclast differentiation have not been revealed. We demonstrate that Akt induces osteoclast differentiation through regulating the GSK3beta/NFATc1 signaling cascade. Inhibition of the PI3K by LY294002 reduces formation of osteoclasts and attenuates the expression of NFATc1, but not that of c-Fos. Conversely, overexpression of Akt in bone marrow-derived macrophages (BMMs) strongly induced NFATc1 expression without affecting c-Fos expression, suggesting that PI3K/Akt-mediated NFATc1 induction is independent of c-Fos during RANKL-induced osteoclastogenesis. In addition, we found that overexpression of Akt enhances formation of an inactive form of GSK3beta (phospho-GSK3beta) and nuclear localization of NFATc1, and that overexpression of a constitutively active form of GSK3beta attenuates osteoclast formation through downregulation of NFATc1. Furthermore, BMMs from SHIP knockout mice show the increased expression levels of phospho-Akt and phospho-GSK3beta, as well as the enhanced osteoclastogenesis, compared with wild type. However, overexpression of a constitutively active form of GSK3beta attenuates RANKL-induced osteoclast differentiation from SHIP-deficient BMMs. Our data suggest that the PI3K/Akt/GSK3beta/NFATc1 signaling axis plays an important role in RANKL-induced osteoclastogenesis. |
